From The Economic Times
Center-Right Owned by Bennett, Coleman & Co.Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-Shaw
RSS excerpt
Biocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push for a shift beyond generics.